Literature DB >> 27166142

Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis.

Helal F Hetta1,2, Mohamed A Mekky3, Nasr K Khalil4, Wegdan A Mohamed2, Mohamed A El-Feky2, Shabaan H Ahmed2, Enas A Daef2, Ahmed Medhat3, Mahmoud I Nassar5, Kenneth E Sherman1, Mohamed Tarek M Shata1.   

Abstract

Extra-hepatic compartments might contribute to hepatitis C virus (HCV) persistence and extra-hepatic manifestations. Therefore, we investigated HCV infection in colonic tissue in patients with chronic hepatitis C (CHC) and its relationship with HCV pathogenesis. Colonic biopsies were collected from three groups with CHC infection: treatment naïve (TN; n=12), non-responders (NR; n=10) to anti-HCV therapy (pegylated interferon-α and ribavirin) and sustained virologic response (SVR; n=10) and from a fourth healthy control group (n=10). Liver biopsies were examined to assess inflammation and fibrosis. HCV infection and colonic T regulatory (Treg) frequency were detected by immunohistochemistry. HCV core and NS3 proteins were detected in B cells and macrophage/monocytes of 42 % and 25 % of TN and 50 % and 30 % of NR, respectively, but not in SVR or control group. The numbers of cells expressing HCV proteins were positively correlated with both HCV viral load and colonic Treg frequency. A significant negative correlation between HCV-expressing cells with both liver inflammation and fibrosis was identified. Our study provides evidence that HCV can infect B cells and macrophages of the colon. The correlations between HCV infection in colonic tissue and HCV viral load and liver pathology underline the significance of this extra-hepatic infection in HCV pathogenesis and response to therapy.

Entities:  

Mesh:

Year:  2016        PMID: 27166142      PMCID: PMC5756491          DOI: 10.1099/jmm.0.000272

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  44 in total

Review 1.  The role of regulatory T cells in chronic and acute viral infections.

Authors:  Yoav Keynan; Catherine M Card; Paul J McLaren; Magdy R Dawood; Ken Kasper; Keith R Fowke
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

2.  Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis.

Authors:  D Sansonno; L Gesualdo; C Manno; F P Schena; F Dammacco
Journal:  Hepatology       Date:  1997-05       Impact factor: 17.425

Review 3.  Hepatitis C virus-associated extrahepatic manifestations: a review.

Authors:  Damien Sène; Nicolas Limal; Patrice Cacoub
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

4.  Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism.

Authors:  Sampa Pal; Daniel G Sullivan; Sean Kim; K Kay-Yin Lai; John Kae; Scott J Cotler; Robert L Carithers; Brent L Wood; James D Perkins; David R Gretch
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 5.  Extrahepatic manifestations of hepatitis C infection.

Authors:  Marlyn J Mayo
Journal:  Am J Med Sci       Date:  2003-03       Impact factor: 2.378

6.  Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells.

Authors:  J T Wang; J C Sheu; J T Lin; T H Wang; D S Chen
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

7.  Hepatic and extrahepatic hepatitis C virus replication in relation to response to interferon therapy.

Authors:  M G Saleh; C J Tibbs; J Koskinas; L M Pereira; A B Bomford; B C Portmann; I G McFarlane; R Williams
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

8.  Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients.

Authors:  D Sansonno; A R Iacobelli; V Cornacchiulo; G Iodice; F Dammacco
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

9.  Reinfection of liver graft by hepatitis C virus after liver transplantation.

Authors:  C Féray; D Samuel; V Thiers; M Gigou; F Pichon; A Bismuth; M Reynes; P Maisonneuve; H Bismuth; C Bréchot
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

Review 10.  Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence.

Authors:  Dennis Revie; Syed Zaki Salahuddin
Journal:  Virol J       Date:  2011-07-11       Impact factor: 4.099

View more
  8 in total

1.  Prognostic impact of toll-like receptors 2 and 4 expression on monocytes in Egyptian patients with hepatocellular carcinoma.

Authors:  Asmaa M Zahran; Zeinab Albadry M Zahran; Omnia El-Badawy; Mona H Abdel-Rahim; Wageeh A M Ali; Amal Rayan; Muhammad Abbas El-Masry; Mohamed A A Abozaid; Helal F Hetta
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

Review 2.  Chronic Viral Hepatitis Is Associated with Colorectal Neoplasia: A Systematic Review and Meta-Analysis.

Authors:  Seung Wook Hong; Won-Mook Choi; Ha Won Hwang; Dae Sung Kim; Jiyoung Yoon; Jin Wook Lee; Ju Hyun Shim; Dong-Hoon Yang; Seung-Jae Myung; Suk-Kyun Yang; Jeong-Sik Byeon
Journal:  Dig Dis Sci       Date:  2021-01-12       Impact factor: 3.199

3.  Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients.

Authors:  Minesh Mehta; Helal F Hetta; Enass A Abdel-Hameed; Susan D Rouster; MdMonir Hossain; Mohamed A Mekky; Nasr K Khalil; Wegdan A Mohamed; Mohamed A El-Feky; Shabaan H Ahmed; Enas A Daef; Mohamed A El-Mokhtar; Sayed F Abdelwahab; Ahmed Medhat; Kenneth E Sherman; Mohamed Tarek M Shata
Journal:  Arch Virol       Date:  2016-08-20       Impact factor: 2.574

4.  Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C.

Authors:  Hala Rady Ahmed; Nancy G F M Waly; Rehab Mahmoud Abd El-Baky; Ramadan Yahia; Helal F Hetta; Amr M Elsayed; Reham Ali Ibrahem
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

5.  Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study.

Authors:  Mohamed A Mekky; Hani I Sayed; Mohamed O Abdelmalek; Medhat A Saleh; Osman A Osman; Heba A Osman; Khairy H Morsy; Helal F Hetta
Journal:  Infect Drug Resist       Date:  2019-01-22       Impact factor: 4.003

6.  Gut DNA Virome Diversity and Its Association with Host Bacteria Regulate Inflammatory Phenotype and Neuronal Immunotoxicity in Experimental Gulf War Illness.

Authors:  Ratanesh K Seth; Rabia Maqsood; Ayan Mondal; Dipro Bose; Diana Kimono; LaRinda A Holland; Patricia Janulewicz Lloyd; Nancy Klimas; Ronnie D Horner; Kimberly Sullivan; Efrem S Lim; Saurabh Chatterjee
Journal:  Viruses       Date:  2019-10-21       Impact factor: 5.048

Review 7.  Cytotoxic Chemotherapy as an Alternative for Systemic Treatment of Advanced Hepatocellular Carcinoma in Developing Countries.

Authors:  Khaled Abouelezz; Dipen Khanapara; Gaber El-Saber Batiha; Esraa A Ahmed; Helal F Hetta
Journal:  Cancer Manag Res       Date:  2020-11-27       Impact factor: 3.989

Review 8.  Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice.

Authors:  Nadia Marascio; Salvatore Rotundo; Angela Quirino; Giovanni Matera; Maria Carla Liberto; Chiara Costa; Alessandro Russo; Enrico Maria Trecarichi; Carlo Torti
Journal:  World J Gastroenterol       Date:  2022-03-28       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.